Malaysian Firm to Sign $2 Million Deal With India's Avestha (Malaysia)
This article was originally published in PharmAsia News
Executive Summary
One of Malaysia's leading pharmaceutical and biotechnology companies has announced a prospective contract with Indian biotechnology manufacturer, Avestha Gengraine Technologies Pvt Ltd. As part of the proposed deal, the Malaysian company, Inno Biologics, will pay Avestha $2 million to produce and supply Inno with saline